Privia Health Group, Inc. ($PRVA)
Filing Information
| Accession Number | 0001759655-26-000013 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 2, 2026 |
| Document | View SEC Filing |
Transactions
12
Total Shares
39,174
Total Value
$352,950.85
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Financial Officer | Common Stock, par value $0.01 per share | โ | Feb 26, 2026 | Exercise/Conversion | 5,361 | $2.00 | $10,722.00 | 178,270 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Common Stock, par value $0.01 per share | โ | Feb 26, 2026 | Sale | 5,361 | $25.00 | $134,025.00 | 172,909 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Common Stock, par value $0.01 per share | โ | Feb 27, 2026 | Exercise/Conversion | 7,697 | $2.00 | $15,394.00 | 180,606 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Common Stock, par value $0.01 per share | โ | Feb 27, 2026 | Sale | 7,697 | $25.05 | $192,809.85 | 172,909 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Stock Option (Right to Purchase) | Derivative | Feb 26, 2026 | Exercise/Conversion | 1,668 | $0.00 | $0.00 | 3,833 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Stock Option (Right to Purchase) | Derivative | Feb 26, 2026 | Exercise/Conversion | 1,100 | $0.00 | $0.00 | 11,352 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Stock Option (Right to Purchase) | Derivative | Feb 26, 2026 | Exercise/Conversion | 1,893 | $0.00 | $0.00 | 15,927 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Stock Option (Right to Purchase) | Derivative | Feb 26, 2026 | Exercise/Conversion | 700 | $0.00 | $0.00 | 2,166 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Stock Option (Right to Purchase) | Derivative | Feb 27, 2026 | Exercise/Conversion | 998 | $0.00 | $0.00 | 2,835 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Stock Option (Right to Purchase) | Derivative | Feb 27, 2026 | Exercise/Conversion | 2,699 | $0.00 | $0.00 | 8,653 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Stock Option (Right to Purchase) | Derivative | Feb 27, 2026 | Exercise/Conversion | 3,428 | $0.00 | $0.00 | 12,499 | Direct | โ | View Details | |
EVP & Chief Financial Officer | Stock Option (Right to Purchase) | Derivative | Feb 27, 2026 | Exercise/Conversion | 572 | $0.00 | $0.00 | 1,594 | Direct | โ | View Details |